Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme (COGLI)

This study has been terminated.
(poor accrual)
Texas Children's Hospital
Center for Cell and Gene Therapy, Baylor College of Medicine
The Methodist Hospital System
Information provided by (Responsible Party):
Nabil Ahmed, Baylor College of Medicine Identifier:
First received: September 17, 2010
Last updated: August 17, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: August 17, 2013